Adrian Danek Selected Research

Neuroacanthocytosis

2/2022	XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease.
1/2022	Erysense, a Lab-on-a-Chip-Based Point-of-Care Device to Evaluate Red Blood Cell Flow Properties With Multiple Clinical Applications.
12/2021	The Erythrocyte Sedimentation Rate and Its Relation to Cell Shape and Rigidity of Red Blood Cells from Chorea-Acanthocytosis Patients in an Off-Label Treatment with Dasatinib.
1/2021	Acanthocyte Sedimentation Rate as a Diagnostic Biomarker for Neuroacanthocytosis Syndromes: Experimental Evidence and Physical Justification.
1/2021	Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis.
1/2020	Identification of two compound heterozygous VPS13A large deletions in chorea-acanthocytosis only by protein and quantitative DNA analysis.
11/2018	Current state of knowledge in Chorea-Acanthocytosis as core Neuroacanthocytosis syndrome.
12/2016	A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis.
3/2013	Mineral deposition on magnetic resonance imaging in chorea-acanthocytosis: a pathogenic link with pantothenate kinase-associated neurodegeneration?
1/2013	Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian Danek Research Topics

Disease

17	Frontotemporal Dementia (Semantic Dementia) 08/2022 - 02/2010
17	Neuroacanthocytosis 02/2022 - 08/2002
16	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2015
10	Dementia (Dementias) 09/2022 - 11/2011
9	Movement Disorders (Movement Disorder) 02/2022 - 08/2005
8	Atrophy 01/2022 - 12/2007
8	Cognitive Dysfunction 01/2021 - 09/2015
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2012
7	Disease Progression 01/2022 - 01/2017
4	Down Syndrome (Down's Syndrome) 09/2022 - 11/2014
4	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 02/2022 - 10/2008
4	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2021 - 12/2017
4	Corticobasal Degeneration 01/2021 - 01/2017
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2017
4	Parkinson Disease (Parkinson's Disease) 01/2019 - 07/2008
4	Primary Progressive Aphasia 01/2019 - 03/2014
4	Mcleod Type Neuroacanthocytosis 11/2018 - 08/2002
3	Chorea (Rheumatic Chorea) 02/2022 - 08/2002
3	Dystonia (Limb Dystonia) 02/2022 - 01/2014
3	Gliosis 01/2022 - 01/2019
3	Neuroinflammatory Diseases 01/2021 - 10/2020
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 01/2017
3	Seizures (Absence Seizure) 12/2019 - 05/2011
3	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 11/2018 - 10/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2022 - 08/2002
2	Epilepsy (Aura) 02/2022 - 01/2022
2	Multiple Sclerosis 01/2022 - 01/2022
2	Basal Ganglia Diseases (Basal Ganglia Disease) 11/2021 - 05/2011
2	Tauopathies 11/2021 - 01/2021
2	Amyloidosis 01/2021 - 09/2015
2	Parkinsonian Disorders (Parkinsonism) 01/2019 - 02/2013
2	Cerebellar Ataxia (Dysmetria) 01/2019 - 09/2011
2	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 11/2018 - 10/2011
2	Hyperkinesis 01/2014 - 01/2013
2	Muscular Diseases (Myopathy) 12/2012 - 08/2002
1	Confusion (Bewilderment) 02/2022
1	Cardiomyopathies (Cardiomyopathy) 02/2022
1	Dizziness (Lightheadedness) 01/2022
1	Stroke (Strokes) 01/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022
1	Central Nervous System Vasculitis 12/2021
1	Cerebral Cortical Thinning 01/2021
1	Myoclonus (Nocturnal Myoclonus) 12/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Multiple System Atrophy 01/2019
1	Rare Diseases (Rare Disease) 11/2018
1	Nervous System Diseases (Neurological Disorders) 11/2018
1	Huntington Disease-Like 2 11/2018

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
13	Proteins (Proteins, Gene)FDA Link 09/2022 - 10/2011
11	Amyloid (Amyloid Fibrils)IBA 09/2022 - 12/2016
7	Creatine Kinase (Creatine Phosphokinase)IBA 02/2022 - 08/2002
5	ProgranulinsIBA 08/2022 - 02/2010
4	GranulinsIBA 01/2022 - 01/2021
4	Lipoproteins (Lipoprotein)IBA 11/2021 - 08/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
3	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2019
3	tau Proteins (tau Protein)IBA 01/2021 - 01/2017
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2011
2	neuronal pentraxinIBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
2	Protein Isoforms (Isoforms)IBA 11/2021 - 01/2021
2	SynucleinsIBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2020 - 01/2012
2	THK5351IBA 01/2019 - 01/2017
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2016 - 04/2011
2	Cholinergic Agents (Cholinergics)IBA 10/2016 - 03/2014
2	Indicators and Reagents (Reagents)IBA 09/2015 - 02/2011
2	Apolipoproteins E (ApoE)IBA 09/2015 - 11/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2022
1	LipidsIBA 02/2022
1	tributyl phosphate (TBP)IBA 01/2022
1	nasIBA 01/2022
1	ponceau 4R (E 124)IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	RNA Splice SitesIBA 01/2022
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2022
1	beta-SynucleinIBA 01/2022
1	Dasatinib (BMS 354825)FDA Link 12/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 12/2021
1	Protein AggregatesIBA 01/2021
1	nilotinib FDA Link 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	LigandsIBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	ioflupaneIBA 01/2020
1	Donepezil (Aricept)FDA LinkGeneric 12/2019
1	Amino Acids FDA Link 12/2019
1	Monoamine Oxidase (MAO)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	Cytoskeletal ProteinsIBA 01/2019
1	HDL2 LipoproteinsIBA 11/2018
1	Familial apoceruloplasmin deficiencyIBA 11/2018

Therapy/Procedure

4	Deep Brain Stimulation 11/2011 - 07/2008
1	Hemodiafiltration 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Duration of Therapy 01/2019